These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2847323

  • 1. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY, Lau YK, Chia KB, Lim CH.
    Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
    [No Abstract] [Full Text] [Related]

  • 2. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 3. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP, Gurtsevich VE, Stepina VN, Plakhov IV.
    Arch Geschwulstforsch; 1983 May; 53(3):253-9. PubMed ID: 6311138
    [No Abstract] [Full Text] [Related]

  • 4. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
    Desgranges C, de-The G.
    IARC Sci Publ (1971); 1978 May; (20):459-69. PubMed ID: 215528
    [No Abstract] [Full Text] [Related]

  • 5. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
    Gurtsevich VE, Plakhov IV, Chuĭkina NA, Abdulin NA.
    Vestn Akad Med Nauk SSSR; 1984 May; (5):29-34. PubMed ID: 6331022
    [No Abstract] [Full Text] [Related]

  • 6. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P, Klein G, Henle W, Henle G, Forsby N.
    Biomed Pharmacother; 1983 May; 37(1):41-4. PubMed ID: 6311307
    [Abstract] [Full Text] [Related]

  • 7. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U, Cevenini R, Donati M.
    Acta Otorhinolaryngol Ital; 1985 May; 5(1):83-90. PubMed ID: 2994355
    [No Abstract] [Full Text] [Related]

  • 8. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M, Prasad U.
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [Abstract] [Full Text] [Related]

  • 9. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J, Haikin H, Sarov B, Háber A, Kun L, Sarov I.
    Acta Microbiol Immunol Hung; 1995 Jun; 42(2):179-87. PubMed ID: 7551711
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W, Henle G, Ho JH.
    IARC Sci Publ (1971); 1978 Jun; (20):427-37. PubMed ID: 215525
    [No Abstract] [Full Text] [Related]

  • 11. IgA and nasopharyngeal carcinoma.
    Desgranges C, De-The G.
    IARC Sci Publ (1971); 1978 Jun; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract] [Full Text] [Related]

  • 12. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
    Tang ZH.
    Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Mar; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 14. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
    Shang M.
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
    [No Abstract] [Full Text] [Related]

  • 15. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
    Tang ZH.
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
    [No Abstract] [Full Text] [Related]

  • 16. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)].
    Liu YX, Zeng Y, Dong WP, Cao GR.
    Zhonghua Zhong Liu Za Zhi; 1979 Sep; 1(1):8-12. PubMed ID: 233233
    [No Abstract] [Full Text] [Related]

  • 17. [Relation between the growth pattern and the quantity of plasma cells of nasopharyngeal cancer (NPC) and serum EBV antibody level].
    Li JT.
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):9-11. PubMed ID: 2983963
    [No Abstract] [Full Text] [Related]

  • 18. [125I] Clq-binding activity and its relationship with anti-Epstein--Barr virus antibodies in sera from nasopharyngeal carcinoma patients.
    Lamelin JP, Vincent C, Souissi T, Revillard JP.
    Eur J Cancer (1965); 1979 Feb; 15(2):163-71. PubMed ID: 220051
    [No Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
    Kottaridis SD, Goula I, Kiparissiadis P.
    Neoplasma; 1982 Feb; 29(3):327-31. PubMed ID: 6290911
    [No Abstract] [Full Text] [Related]

  • 20. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
    Henle W, Ho JH, Henle G, Chau JC, Kwan HC.
    Int J Cancer; 1977 Nov 15; 20(5):663-72. PubMed ID: 200569
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.